Additionally, the tirzepatide group had a higher percentage of White patients (67.3% vs 60.4%; P < .001), whereas the GLP-1 RA group had higher percentages of Black (20.1% vs 17.0%), Asian (3.6% vs 2.3%), and Hispanic or Latinx (9.3% vs 6.5%) patients; and a higher percentage of female patients (56.9% vs 53.8%; P < .001), whereas the GLP-1 RA group a higher percentage of males (42.5% vs 37.5%). The gene discussed is GLP1R; the disease is rheumatoid arthritis.